Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Interferon-alpha. Found 8 abstracts

Chisari FV, Mason WS, Seeger C. Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA". Science (New York, NY). 2014 Jun 13;344(6189):1237.   PMCID: Comment
Plimack ER, Desai JR, Issa JP, Jelinek J, Sharma P, Vence LM, Bassett RL, Ilagan JL, Papadopoulos NE, Hwu WJ. A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: Impact on DNA methylation and lymphocyte populations. Investigational New Drugs. 2014 Oct;32(5):969-75.   PMCID: 4171200
Dutcher JP, de Souza P, McDermott D, Figlin RA, Berkenblit A, Thiele A, Krygowski M, Strahs A, Feingold J, Hudes G. Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Medical Oncology . 2009 Jan;26(2):202-9.   PMCID: not NIH funded
Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer. 2009 May;115(9):1859-66.
Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ, Global AT. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. New England Journal of Medicine. 2007 May 31;356(22):2271-81.
Hayashi J, Stoyanova R, Seeger C. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology. 2005 May 10;335(2):264-75.
Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol. 2001 Sep;75(18):8516-23.
Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer. 1999 Jan 15;85(2):290-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Interferon-alpha

Interferon-alpha Male drug therapy Female Antineoplastic Combined Chemotherapy Protocols Aged therapeutic use pharmacology Middle Aged Neoplasm Metastasis chemically induced US Gov't Support-PHS 0 (Interferon-alpha) metabolism pathology Antiviral Agents dosage adverse effects Renal Cell Carcinoma Treatment Outcome Human Adult Replicon drug effects Virus Replication Hepacivirus Kidney Neoplasms Cell Line administration & dosage pa [Pathology] genetics Polyethylene Glycols analogs & derivatives EC 2-7-1-37 (Protein Kinases) Viral DNA dt [Drug Therapy] Circular DNA adverse Sirolimus Mutagenesis Hepatitis B virus ge [Genetics] EC 2-7-1 (mTOR protein) ci [Chemically Induced] me [Metabolism] effects Retrospective Studies Protein Kinases Prognosis Viral RNA administration & Recombinant Proteins Fluorouracil agonists Antineoplastic Agents Stomach Neoplasms pd [Pharmacology] Leukocyte Count Neutropenia Protein Kinase Inhibitors de [Drug Effects] immunology Quality Control tu [Therapeutic Use] administration & Stomatitis 53123-88-9 (Sirolimus) Hepatitis B Research Design Non-US Gov't Support Hela Cells Angiogenesis Inhibitors Hematologic Diseases Melanoma Genetic Transcription physiology Lymphotoxin beta Receptor Maximum Tolerated Dose DNA Methylation mo [Mortality] Survival Analysis Middle Age Gene Expression Profiling Disease Progression Physiological Adaptation Viral Genome 80 and over Aged Disease-Free Survival Tumor histology Leucovorin aa [Analogs & Derivatives] Non-US Gov't Research Support Viral Gene Expression Regulation 0 (Protein Kinase Inhibitors) 0 (Antineoplastic Agents) Local Neoplasm Recurrence Recurrence ph [Physiology] Azacitidine ae [Adverse Effects] Oligonucleotide Array Sequence Analysis Viral Genes Hepatocytes tu [Therapeutic Use] Outcome Assessment (Health Care) Agranulocytosis Proportional Hazards Models Temsirolimus sc [Secondary] T-Lymphocyte Subsets Renal cell carcinoma 0 (cci 779) Viral) 0 (RNA
Last updated on Wednesday, August 12, 2020